Tendon reflexes were absent, and sensory examination was normal

Tendon reflexes were absent, and sensory examination was normal. further confirmed as limb-girdle muscular dystrophy (LGMD2) or myotonic dystrophy (DM1) by molecular analyses. Specifically, we recognized a 4qB variant on chromosome 10 in the healthy members of the fourth FSHD family with complex D4Z4 rearrangements of two exchanged repeat arrays. For the first time, we demonstrated in the Chinese populace that D4Z4 contractions around the 4qB variant do not cause FSHD and 4qB variant on chromosome 10 might also represent intermediate structures in the transition from 4q to 10q. Furthermore, our results emphasize that D4Z4 repeat length analysis alone is not sufficient Rabbit Polyclonal to GPROPDR for the diagnosis of FSHD, especially when used as an exclusion criterion. This analysis should be accompanied by 4qA/4qB variant determination and integrated chromosome assignments, especially in patients with obscure and unclassified myopathies much like atypical forms of FSHD. Keywords:Facioscapulohumeral muscular dystrophy, genetic diagnosis, 4qA/4qB variants, chromosome assignment == Introduction == Facioscapulohumeral muscular dystrophy (FSHD, MIM 158 900) is an autosomal dominant disorder that presents the third most common human muscular dystrophy, affecting skeletal muscles in a pattern that starts in the facial, shoulder and upper arm muscle tissue and gradually progresses to the abdominal and foot-extensor muscle tissue.1Although FSHD can be diagnosed using well-established diagnostic criteria,2there is extreme intrafamilial and interfamilial variability in age at onset, severity and progression of the disease. Moreover, other myopathies can present a clinical picture that resembles FSHD, resulting in misdiagnosis. Because the genetic defect of FSHD has been mapped to the 4q35 subtelomere, it has been recommended that this clinical diagnosis be confirmed via the screening of contractions of D4Z4 repeat arrays located on a 4qter subtelomere.3,4,5Furthermore, several reports have confirmed that there are 4qA and 4qB variants of the 4q subtelomere, and FSHD is uniquely associated with the 4qA variant.6,7,8,9,10These findings add to the diagnostic challenge and pathogenetic complexity.11Therefore, the correct diagnosis of FSHD depends on the ability to distinguish the 4qA and 4qB variants. However, all published data regarding the identification of the 4qA and 4qB variants are limited to the Caucasian populace, and few are related to the Chinese population. In a previous study, we detected the 4qA and 4qB variants in a group of patients that included those who had been formerly diagnosed with FSHD based exclusively around the D4Z4 repeats length analysis.12,13Four families were identified as carriers of the 4qB variant, and one of them had a complex genetic constitution. Monomethyl auristatin E To better characterize Monomethyl auristatin E these patients and to confirm the correct diagnosis, we performed a detailed clinical and genetic re-evaluation. Monomethyl auristatin E The results revealed that the individuals who carried the 4qB variant were previously misdiagnosed with FSHD. These results also confirmed that this 4qB variant does not cause FSHD in the Chinese population. == Materials and methods == == Subjects and PFGE-based DNA analysis == PFGE-based analysis of D4Z4 repeats and the identification of 4qA and 4qB variants using probes p13E-11, 4qA and 4qB were performed as previously reported, in users of 55 clinically diagnosed Chinese FSHD families.6,12,13Four families were found to have a FSHD-sized 4qB-type D4Z4 repeat. These families were subjected to further clinical examinations and molecular analyses. A ten-grade clinical severity (CS) level score14was used to evaluate the phenotypes of the affected individuals. To identify the chromosomal origin of these fragments,NotI-digested DNA was Monomethyl auristatin E hybridized to the chromosome 4-specific probe B31, as previously reported.15Informed consent was obtained from each patient (if <18 years of age, consent was obtained from their legal guardians). The research protocol was approved by the local Ethics Committee for medical research. == Western blot analysis == Western blot analysis of protein extracts from muscle mass biopsy specimens was performed using a calpain 3 rabbit polyclonal antibody Monomethyl auristatin E (H-80; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), a dysferlin rabbit monoclonal antibody (Epitomics Inc., Burlingame, CA, USA), a-sarcoglycan rabbit polyclonal antibody (H-98; Santa Cruz Biotechnology Inc.) and a GAPDH.